Movatterモバイル変換


[0]ホーム

URL:


US20050147531A1 - Devices comprising multiple capillary inducing surfaces - Google Patents

Devices comprising multiple capillary inducing surfaces
Download PDF

Info

Publication number
US20050147531A1
US20050147531A1US10/746,282US74628203AUS2005147531A1US 20050147531 A1US20050147531 A1US 20050147531A1US 74628203 AUS74628203 AUS 74628203AUS 2005147531 A1US2005147531 A1US 2005147531A1
Authority
US
United States
Prior art keywords
capillarity
region
structures
distal
inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/746,282
Inventor
Kenneth Buechler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere San Diego Inc
Original Assignee
Biosite Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosite IncfiledCriticalBiosite Inc
Priority to US10/746,282priorityCriticalpatent/US20050147531A1/en
Publication of US20050147531A1publicationCriticalpatent/US20050147531A1/en
Assigned to GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENTreassignmentGENERAL ELECTRIC CAPITAL CORPORATION, AS AGENTSECURITY AGREEMENTAssignors: BIOSITE INCORPORATED
Assigned to GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENTreassignmentGENERAL ELECTRIC CAPITAL CORPORATION, AS AGENTSECURITY AGREEMENTAssignors: BIOSITE INCORPORATED
Abandonedlegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

Assay device structures for a device where fluid flows from a one region to another. The device structures comprising one or more capillarity-inducing structures; where the capillarity-inducing structure induces capillary force along an axis that is essentially perpendicular to the axis along which capillary force induced in another region of the device.

Description

Claims (1)

US10/746,2821996-11-152003-12-24Devices comprising multiple capillary inducing surfacesAbandonedUS20050147531A1 (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
US10/746,282US20050147531A1 (en)1996-11-152003-12-24Devices comprising multiple capillary inducing surfaces

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US08/749,702US6113855A (en)1996-11-151996-11-15Devices comprising multiple capillarity inducing surfaces
US09/612,815US6669907B1 (en)1996-11-152000-07-10Devices comprising multiple capillarity inducing surfaces
US10/746,282US20050147531A1 (en)1996-11-152003-12-24Devices comprising multiple capillary inducing surfaces

Related Parent Applications (1)

Application NumberTitlePriority DateFiling Date
US09/612,815ContinuationUS6669907B1 (en)1996-11-152000-07-10Devices comprising multiple capillarity inducing surfaces

Publications (1)

Publication NumberPublication Date
US20050147531A1true US20050147531A1 (en)2005-07-07

Family

ID=25014818

Family Applications (3)

Application NumberTitlePriority DateFiling Date
US08/749,702Expired - LifetimeUS6113855A (en)1996-11-151996-11-15Devices comprising multiple capillarity inducing surfaces
US09/612,815Expired - LifetimeUS6669907B1 (en)1996-11-152000-07-10Devices comprising multiple capillarity inducing surfaces
US10/746,282AbandonedUS20050147531A1 (en)1996-11-152003-12-24Devices comprising multiple capillary inducing surfaces

Family Applications Before (2)

Application NumberTitlePriority DateFiling Date
US08/749,702Expired - LifetimeUS6113855A (en)1996-11-151996-11-15Devices comprising multiple capillarity inducing surfaces
US09/612,815Expired - LifetimeUS6669907B1 (en)1996-11-152000-07-10Devices comprising multiple capillarity inducing surfaces

Country Status (6)

CountryLink
US (3)US6113855A (en)
EP (1)EP0938659B1 (en)
AT (1)ATE233896T1 (en)
AU (1)AU5438598A (en)
DE (1)DE69719536T2 (en)
WO (1)WO1998021563A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20050136552A1 (en)*1992-05-212005-06-23Biosite, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US20060289787A1 (en)*2005-06-172006-12-28Amic AbOptical assay system
US20070154970A1 (en)*1998-01-052007-07-05Biosite, Inc.Methods for monitoring the status of assays and immunoassays
US7713703B1 (en)2000-11-132010-05-11Biosite, Inc.Methods for monitoring the status of assays and immunoassays
US7824611B2 (en)1992-05-212010-11-02Biosite, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US20100296972A1 (en)*2008-02-012010-11-25Toru MiuraFlow cell
US9329128B2 (en)2008-11-072016-05-03Roche Diabetes Care, Inc.Test element for detecting an analyte in a sample
WO2020068548A1 (en)*2018-09-252020-04-02Siemens Healthcare Diagnostics Inc.Compositions, kits, and methods for multiplex assays to correct for biotin interference in target analyte measurements

Families Citing this family (216)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6113855A (en)*1996-11-152000-09-05Biosite Diagnostics, Inc.Devices comprising multiple capillarity inducing surfaces
US7914994B2 (en)*1998-12-242011-03-29CepheidMethod for separating an analyte from a sample
US6319719B1 (en)*1999-10-282001-11-20Roche Diagnostics CorporationCapillary hematocrit separation structure and method
JP2003524193A (en)*2000-02-232003-08-12ザイオミックス インコーポレイテッド Chip with sample surface positioned high
US7981420B2 (en)2000-12-222011-07-19Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V.Therapeutic use of antibodies directed against repulsive guidance molecule (RGM)
US7713705B2 (en)*2002-12-242010-05-11Biosite, Inc.Markers for differential diagnosis and methods of use thereof
US7632647B2 (en)*2001-04-132009-12-15Biosite IncorporatedUse of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US20040126767A1 (en)*2002-12-272004-07-01Biosite IncorporatedMethod and system for disease detection using marker combinations
US7524635B2 (en)*2003-04-172009-04-28Biosite IncorporatedMethods and compositions for measuring natriuretic peptides and uses thereof
US20030199000A1 (en)*2001-08-202003-10-23Valkirs Gunars E.Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20030219734A1 (en)*2001-04-132003-11-27Biosite IncorporatedPolypeptides related to natriuretic peptides and methods of their identification and use
US20040253637A1 (en)*2001-04-132004-12-16Biosite IncorporatedMarkers for differential diagnosis and methods of use thereof
US20040203083A1 (en)*2001-04-132004-10-14Biosite, Inc.Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
US20040121350A1 (en)*2002-12-242004-06-24Biosite IncorporatedSystem and method for identifying a panel of indicators
US6759009B2 (en)2001-05-042004-07-06Portascience IncorporatedMethod and device for clotting time assay
AU2002305394A1 (en)2001-05-042002-11-18Biosite, Inc.Diagnostic markers of acute coronary syndromes and methods of use thereof
US20040219509A1 (en)*2001-08-202004-11-04Biosite, Inc.Diagnostic markers of stroke and cerebral injury and methods of use thereof
EP1419388B1 (en)*2001-08-202009-10-07Biosite IncorporatedDiagnostic markers of stroke and cerebral injury and methods of use thereof
US6919058B2 (en)*2001-08-282005-07-19Gyros AbRetaining microfluidic microcavity and other microfluidic structures
CA2471925A1 (en)*2002-01-042003-07-24Peter R.C. GascoyneWall-less channels for fluidic routing and confinement
US7459127B2 (en)*2002-02-262008-12-02Siemens Healthcare Diagnostics Inc.Method and apparatus for precise transfer and manipulation of fluids by centrifugal and/or capillary forces
US7223368B2 (en)2002-05-032007-05-29Kimberly-Clark Worldwide, Inc.Diffraction-based diagnostic devices
US7223534B2 (en)2002-05-032007-05-29Kimberly-Clark Worldwide, Inc.Diffraction-based diagnostic devices
US7214530B2 (en)*2002-05-032007-05-08Kimberly-Clark Worldwide, Inc.Biomolecule diagnostic devices and method for producing biomolecule diagnostic devices
US7485453B2 (en)*2002-05-032009-02-03Kimberly-Clark Worldwide, Inc.Diffraction-based diagnostic devices
US7771922B2 (en)2002-05-032010-08-10Kimberly-Clark Worldwide, Inc.Biomolecule diagnostic device
US7118855B2 (en)*2002-05-032006-10-10Kimberly-Clark Worldwide, Inc.Diffraction-based diagnostic devices
US7091049B2 (en)2002-06-262006-08-15Kimberly-Clark Worldwide, Inc.Enhanced diffraction-based biosensor devices
KR100480338B1 (en)*2002-08-082005-03-30한국전자통신연구원Microfluidic devices for the controlled movements of solution
US7169550B2 (en)*2002-09-262007-01-30Kimberly-Clark Worldwide, Inc.Diffraction-based diagnostic devices
KR100444751B1 (en)*2002-11-112004-08-16한국전자통신연구원Device of Controlling Fluid using Surface Tension
JP4253178B2 (en)*2002-12-022009-04-08アークレイ株式会社 Method for manufacturing analytical tool
US7094354B2 (en)2002-12-192006-08-22Bayer Healthcare LlcMethod and apparatus for separation of particles in a microfluidic device
US7125711B2 (en)2002-12-192006-10-24Bayer Healthcare LlcMethod and apparatus for splitting of specimens into multiple channels of a microfluidic device
US7341838B2 (en)2003-04-172008-03-11Biosite IncorporatedPolypeptides related to natriuretic peptides and methods of their identification and use
US7435381B2 (en)*2003-05-292008-10-14Siemens Healthcare Diagnostics Inc.Packaging of microfluidic devices
US7347617B2 (en)2003-08-192008-03-25Siemens Healthcare Diagnostics Inc.Mixing in microfluidic devices
US7582472B2 (en)*2003-08-262009-09-01Smith Kenneth EApparatus and method for liquid sample testing
CA2537668A1 (en)*2003-09-292005-04-14Biosite IncorporatedMethods and compositions for the diagnosis of sepsis
DE10354806A1 (en)*2003-11-212005-06-02Boehringer Ingelheim Microparts Gmbh sample carrier
DE10360220A1 (en)*2003-12-202005-07-21Steag Microparts GmbhFine structure arrangement in fluid ejection system, has predetermined region in transitional zone between inlet and discharge ports, at which capillary force is maximum
WO2005095967A1 (en)*2004-03-232005-10-13Quidel CorporationHybrid phase lateral flow assay
SE0400662D0 (en)*2004-03-242004-03-24Aamic Ab Assay device and method
US20060105419A1 (en)*2004-08-162006-05-18Biosite, Inc.Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions
JP2007523355A (en)*2004-08-212007-08-16エルジー・ライフ・サイエンシズ・リミテッド Microfluidic device and diagnostic and analytical apparatus including the same
EP1794588A2 (en)*2004-09-092007-06-13Biosite IncorporatedMethods and compositions for measuring canine bnp and uses thereof
US20080050832A1 (en)*2004-12-232008-02-28Buechler Kenneth FMethods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
US7879979B2 (en)*2005-01-212011-02-01Alere InternationalArginine analogs, and methods for their synthesis and use
US7611908B2 (en)2005-05-022009-11-03Bioscale, Inc.Method and apparatus for therapeutic drug monitoring using an acoustic device
US7300631B2 (en)2005-05-022007-11-27Bioscale, Inc.Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles
US7749445B2 (en)2005-05-022010-07-06Bioscale, Inc.Method and apparatus for analyzing bioprocess fluids
US7648844B2 (en)2005-05-022010-01-19Bioscale, Inc.Method and apparatus for detection of analyte using an acoustic device
US20070269836A1 (en)*2005-06-092007-11-22Mcpherson Paul HMethods and compositions for the diagnosis of venous thromboembolic disease
WO2007028070A2 (en)*2005-08-302007-03-08Biosite, Inc.Use of soluble flt-1 and its fragments in cardiovascular conditions
ES2542501T3 (en)2005-09-302015-08-06Abbvie Deutschland Gmbh & Co Kg Protein binding domains of the protein family of repulsive targeting molecules (RGM) and functional fragments thereof, as well as their use
US8133741B2 (en)2005-10-262012-03-13General Electric CompanyMethods and systems for delivery of fluidic samples to sensor arrays
US7723120B2 (en)*2005-10-262010-05-25General Electric CompanyOptical sensor array system and method for parallel processing of chemical and biochemical information
US7871568B2 (en)2006-01-232011-01-18Quidel CorporationRapid test apparatus
US7794656B2 (en)2006-01-232010-09-14Quidel CorporationDevice for handling and analysis of a biological sample
EP2005168A4 (en)*2006-03-092009-05-20Biosite IncMethods and compositions for the diagnosis of diseases of the aorta
US20080118924A1 (en)*2006-05-262008-05-22Buechler Kenneth FUse of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
GB0611116D0 (en)2006-06-062006-07-19Oxford Genome Sciences Uk LtdProteins
ATE528411T1 (en)2006-06-072011-10-15Otago Innovation Ltd DIAGNOSTIC METHODS AND MARKERS
WO2008094198A2 (en)*2006-07-282008-08-07Biosite IncorporatedDevices and methods for performing receptor binding assays using magnetic particles
EP2089722B1 (en)2006-09-072017-11-08Otago Innovation LimitedBiomarker for early detection of acute cardiac disorders
EP2095106B1 (en)*2006-11-142013-03-20Alere San Diego, Inc.Methods and compositions for diagnosis and prognosis of renal artery stenosis
EP2095107B1 (en)2006-11-142014-07-02Alere San Diego, Inc.Methods for risk assignment
US20080118402A1 (en)*2006-11-212008-05-22David BrancazioMethod and apparatus for analyte processing
US8202491B2 (en)2006-11-212012-06-19Bioscale, Inc.Apparatus for analyte processing
US20090004755A1 (en)*2007-03-232009-01-01Biosite, IncorporatedMethods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
US8221995B2 (en)*2007-03-232012-07-17Seok-Won LeeMethods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
EP1977829A1 (en)*2007-03-292008-10-08Roche Diagnostics GmbHDevice for performing multiple analyses in parallel
US7883898B2 (en)*2007-05-072011-02-08General Electric CompanyMethod and apparatus for measuring pH of low alkalinity solutions
US20080295909A1 (en)*2007-05-242008-12-04Locascio Laurie EMicrofluidic Device for Passive Sorting and Storage of Liquid Plugs Using Capillary Force
WO2009033056A1 (en)2007-09-062009-03-12Bioscale, Inc.Reusable detection surfaces and methods of using same
WO2009034563A2 (en)2007-09-142009-03-19Nanocomms Patents LimitedAn analysis system
US8962803B2 (en)2008-02-292015-02-24AbbVie Deutschland GmbH & Co. KGAntibodies against the RGM A protein and uses thereof
AU2009224113B2 (en)2008-03-122013-02-21Otago Innovation LimitedBiomarkers
WO2009113880A1 (en)2008-03-122009-09-17Christopher Joseph PembertonBiomarkers
SE533514C2 (en)*2008-06-162010-10-12Aamic Ab Analytical apparatus and method
CN105067819B (en)2008-08-282018-05-22阿斯图特医药公司Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2813848A3 (en)2008-08-292015-03-11Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2172260A1 (en)*2008-09-292010-04-07Corning IncorporatedMultiple flow path microfluidic devices
NZ607703A (en)2008-10-212014-09-26Astute Medical IncMethods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010048347A2 (en)2008-10-212010-04-29Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of renal injury and renal failure
BRPI0922021A2 (en)2008-11-102019-09-24Astute Medical Inc method for assessing kidney condition in an individual, and use of one or more markers of kidney injury
CN104034901A (en)2008-11-222014-09-10阿斯图特医药公司Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20100204055A1 (en)*2008-12-052010-08-12Bonner-Ferraby Phoebe WAutoantibody detection systems and methods
US20100143194A1 (en)*2008-12-082010-06-10Electronics And Telecommunications Research InstituteMicrofluidic device
JP2012517594A (en)2009-02-062012-08-02アスチュート メディカル,インコーポレイテッド Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2751430A1 (en)2009-02-062010-08-12Astute Medical, Inc.Diagnosis and prognosis of renal injury and renal failure
US9752191B2 (en)2009-07-092017-09-05The Scripps Research InstituteGene expression profiles associated with chronic allograft nephropathy
NZ598035A (en)2009-08-072014-06-27Astute Medical IncMethods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102576011B (en)2009-08-072014-09-17阿斯图特医药公司Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2772336A1 (en)2009-08-282011-03-03Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ598741A (en)2009-09-182013-07-26Astute Medical IncMethods and composition for diagnosis and prognosis of renal injury and renal failure by performing assays to detect metalloproteinase inhibitor 4 on a body fluid sample
NZ630277A (en)2009-09-212015-02-27Astute Medical IncMethods and compositions for diagnosis and prognosis of renal injury and renal failure
EA201290192A1 (en)2009-11-072013-02-28Астьют Медикал, Инк. METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PREDICTION OF KIDNEY DAMAGE AND RENAL FAILURE
NZ624614A (en)2009-11-072015-10-30Astute Medical IncMethods and compositions for diagnosis and prognosis of renal injury and renal failure
DK2510001T3 (en)2009-12-082016-02-29Abbvie Deutschland MONOCLONAL ANTIBODIES AGAINST RGM A PROTEIN USED TO TREAT DEGENERATION OF THE RETINAL NERVE FIBER LAYER
EP3112871B1 (en)2009-12-202020-07-29Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX366653B (en)2010-02-052019-07-17Astute Medical IncMETHODS and COMPOSITIONS FOR DIAGNOSIS and PROGNOSIS OF RENAL INJURY and RENAL FAILURE.
CA2789147A1 (en)2010-02-052011-08-11Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102884205B (en)2010-02-052016-05-04阿斯图特医药公司Be used for the method and composition of the diagnosis and prognostic of injury of kidney and kidney failure
WO2011162819A1 (en)2010-06-232011-12-29Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011162820A1 (en)2010-06-232011-12-29Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2012048082A2 (en)2010-10-072012-04-12Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2011220413B2 (en)2010-02-262015-07-23Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US9199232B2 (en)2010-04-072015-12-01Biosensia Patents LimitedFlow control device for assays
JP5786020B2 (en)2010-04-162015-09-30アボットジャパン株式会社 Methods and reagents for diagnosing rheumatoid arthritis
EP2585827A4 (en)2010-06-232013-12-04Astute Medical Inc METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL FAILURE
DK2596010T3 (en)2010-07-192017-07-31Otago Innovation Ltd SIGNAL biomarkers
JP2013541005A (en)2010-09-242013-11-07アスチュート メディカル,インコーポレイテッド Methods and compositions for the assessment of renal injury using hyaluronic acid
US10557856B2 (en)2010-09-242020-02-11University Of Pittsburgh-Of The Commonwealth System Of Higher EducationBiomarkers of renal injury
EP2646822B1 (en)2010-11-292017-11-01Alere San Diego, Inc.Methods for diagnosis and risk prediction in heart failure
EP2661626B1 (en)2011-01-082016-06-01Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2668497B1 (en)2011-01-262020-03-25University of Pittsburgh - Of the Commonwealth System of Higher EducationUrine biomarkers for prediction of recovery after acute kidney injury : proteomics
EP2668499A4 (en)2011-01-292015-05-27Astute Medical IncMethods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3489690A1 (en)2011-08-262019-05-29Astute Medical, Inc.Methods and compositions for evaluation of the renal status
IN2014MN00949A (en)2011-11-222015-04-24Astute Medical Inc
EP2788759B1 (en)2011-12-082019-02-20Astute Medical, Inc.Methods and uses for diagnosis of renal injury and renal failure
WO2013090633A2 (en)2011-12-142013-06-20AbbVie Deutschland GmbH & Co. KGComposition and method for the diagnosis and treatment of iron-related disorders
CA2855840C (en)2011-12-142023-08-29AbbVie Deutschland GmbH & Co. KGComposition and method for the diagnosis and treatment of iron-related disorders
BR102013001328A2 (en)2012-01-202015-05-12Ortho Clinical Diagnostics Inc Teaching device having uniform flow near corners
MX352772B (en)2012-01-272017-12-07Abbvie DeutschlandComposition and method for diagnosis and treatment of diseases associated with neurite degeneration.
JP6538353B2 (en)2012-02-272019-07-03アスチュート メディカル,インコーポレイテッド Methods and compositions for diagnosis and prognosis of kidney injury and failure
CA2866220A1 (en)2012-03-132013-09-19Abbvie Inc.Method for selecting or identifying a subject for v1b antagonist therapy
CN104470942B (en)2012-03-202018-12-14奥塔哥创新有限公司Biomarker
EP3699591A1 (en)2012-04-022020-08-26Astute Medical, Inc.Methods for diagnosis and prognosis of sepsis
WO2013163345A1 (en)2012-04-242013-10-31Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury
US20150177260A1 (en)2012-07-232015-06-25Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of sepsis
US10081842B2 (en)2012-08-072018-09-25The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc.Prostate cancer gene expression profiles
US20150241415A1 (en)2012-08-112015-08-27Astute Medical, Inc.Evaluating renal injury using hyaluronic acid
CA3129014A1 (en)*2012-11-152014-05-15Ortho-Clinical Diagnostics, Inc.Quality/process control of a lateral flow assay device based on flow monitoring
EP2925884B1 (en)2012-11-272018-01-31Luxembourg Institute of HealthCompositions and methods for evaluating heart failure
ES2681955T3 (en)2013-01-172018-09-17Astute Medical, Inc. Methods and compositions for the diagnosis and prognosis of renal injury and renal insufficiency
WO2014152657A1 (en)2013-03-142014-09-25Alere San Diego, Inc.6-acetylmorphine analogs, and methods for their synthesis and use
US9469686B2 (en)2013-03-152016-10-18Abbott LaboratoriesAnti-GP73 monoclonal antibodies and methods of obtaining the same
EP3004873B1 (en)2013-06-052024-01-24Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3003372B1 (en)2013-06-072019-10-09Duke UniversityInhibitors of complement factor h
KR20160039682A (en)2013-08-072016-04-11아스튜트 메디컬 인코포레이티드Assays for timp2 having improved performance in biological samples
SG11201601202WA (en)2013-08-232016-03-30Reata Pharmaceuticals IncMethods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof
WO2015031626A1 (en)2013-08-282015-03-05Abbvie Inc.Soluble cmet assay
WO2015179773A1 (en)2014-05-222015-11-26The Scripps Research InstituteTissue molecular signatures of kidney transplant rejections
EP3047270A4 (en)2013-09-202017-07-19Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain
BR112016010106A2 (en)2013-11-062017-12-05Astute Medical Inc best performing igfbp7 assays on biological samples
CN110007084B (en)2013-12-032022-11-18阿斯图特医药公司 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3090067B1 (en)2013-12-302020-07-22The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.Genomic rearrangements associated with prostate cancer and methods of using the same
WO2015179771A2 (en)2014-05-222015-11-26The Scripps Research InstituteMolecular signatures for distinguishing liver transplant rejections or injuries
WO2015179777A2 (en)2014-05-222015-11-26The Scripps Research InstituteGene expression profiles associated with sub-clinical kidney transplant rejection
US11104951B2 (en)2014-05-222021-08-31The Scripps Research InstituteMolecular signatures for distinguishing liver transplant rejections or injuries
US10443100B2 (en)2014-05-222019-10-15The Scripps Research InstituteGene expression profiles associated with sub-clinical kidney transplant rejection
MX388231B (en)2014-10-202025-03-19Astute Medical Inc METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF KIDNEY INJURY AND KIDNEY FAILURE.
WO2016100912A1 (en)2014-12-182016-06-23Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3281011B1 (en)2015-04-092024-06-05Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK1249467A1 (en)2015-05-122018-11-02阿斯图特医药公司Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK1248808A1 (en)2015-06-112018-10-19阿斯图特医药公司Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20180224466A1 (en)2015-06-172018-08-09Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain
WO2017011329A1 (en)2015-07-102017-01-19West Virginia UniversityMarkers of stroke and stroke severity
EP3458439B1 (en)2016-05-182021-12-08Alere San Diego, Inc.2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine analogs and methods for their synthesis and use
US11243217B2 (en)2016-06-062022-02-08Astute Medical, Inc.Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
NL2017267B1 (en)2016-07-292018-02-01Aduro Biotech Holdings Europe B VAnti-pd-1 antibodies
AU2017339809B2 (en)2016-10-032022-02-17Abbott LaboratoriesImproved methods of assessing UCH-L1 status in patient samples
EP3522893B1 (en)2016-10-042024-12-04University Of Maryland, BaltimoreMethods of treating sepsis using anti-sepsis lipid a (asla) based therapeutics
JP6633812B2 (en)2016-11-082020-01-22リアタ ファーマシューティカルズ インコーポレイテッド Method of treating alport syndrome using bardoxolone methyl or analogs thereof
US11353465B2 (en)2017-01-122022-06-07Astute Medical, Inc.Methods and compositions for evaluation and treatment of renal injury and renal failure based on C—C motif chemokine ligand 14 measurement
CN110678751A (en)2017-03-092020-01-10克利拉生物技术有限公司Biomarkers for cellular senescence
JP7346300B2 (en)2017-03-232023-09-19アボット・ラボラトリーズ Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in human subjects using the early biomarker ubiquitin carboxy-terminal hydrolase L1
CN110546513A (en)2017-04-152019-12-06雅培实验室 Method for aiding hyperacute diagnosis and determination of traumatic brain injury in human subjects using early biomarkers
CN110603449A (en)2017-04-282019-12-20雅培实验室Method for determining traumatic brain injury using early biomarkers from at least two samples of the same human subject for aiding hyperacute diagnosis
US10865238B1 (en)2017-05-052020-12-15Duke UniversityComplement factor H antibodies
CN110753700A (en)2017-05-072020-02-04机敏医药股份有限公司Use of insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinase 2 in the management of renal replacement therapy
CN110651190A (en)2017-05-252020-01-03雅培实验室Method for using early biomarkers to help determine whether to perform imaging on a human subject who has suffered or may have suffered a head injury
AU2018275236B2 (en)2017-05-302024-11-07Abbott LaboratoriesMethods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I
EP3649474A1 (en)2017-07-032020-05-13Abbott LaboratoriesImproved methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in blood
JP7379165B2 (en)2017-12-092023-11-14アボット・ラボラトリーズ Methods for aiding in diagnosing and assessing traumatic brain injury in human subjects using a combination of GFAP and UCH-L1
CN111094983A (en)2017-12-092020-05-01雅培实验室Methods of using Glial Fibrillary Acidic Protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1(UCH-L1) to aid in the diagnosis and evaluation of patients who have suffered orthopedic injury and who have suffered or may have suffered a head injury such as mild Traumatic Brain Injury (TBI)
US11891439B2 (en)2017-12-282024-02-06Astute Medical, Inc.Antibodies and assays for CCL14
BR112020010430A2 (en)2017-12-292020-11-24Abbott Laboratories biomarkers and innovative methods to diagnose and evaluate traumatic brain injury
CN112119151B (en)2018-03-022025-08-29量子细胞公司 Methods, compositions and devices for isolating and analyzing regions of interest from tissues for expression analysis
US12235273B2 (en)2018-05-042025-02-25Abbott LaboratoriesHBV diagnostic, prognostic, and therapeutic methods and products
EP4043015A1 (en)2018-09-042022-08-17H. Lee Moffitt Cancer Center And Research Institute, Inc.Delta-tocotrienol for treating cancer
JP7493513B2 (en)2018-12-282024-05-31アボット・ラボラトリーズ Direct detection of single molecules on microparticles
WO2020144535A1 (en)2019-01-082020-07-16Aduro Biotech Holdings, Europe B.V.Methods and compositions for treatment of multiple myeloma
WO2020180695A1 (en)2019-03-012020-09-10Abbott LaboratoriesMethods for predicting major adverse cardiovascular events in subjects with coronary artery disease
CA3132338A1 (en)2019-04-052020-10-08David SuhyImproved methods and compositions for synthetic biomarkers
EP4136459A1 (en)2020-04-132023-02-22Abbott LaboratoriesMethods, complexes and kits for detecting or determining an amount of a ss-coronavirus antibody in a sample
IL298008A (en)2020-05-092023-01-01Reata Pharmaceuticals Holdings LlcMethods of treating covid-19 using bardoxolone methyl or analogs thereof
BR112022022986A2 (en)2020-05-132023-01-17Disc Medicine Inc ANTI-HEMOJUVELIN (HJV) ANTIBODIES TO TREAT MYELOFIBROSIS
MX2022015287A (en)2020-06-012023-02-22Loop Diagnostics S LMethod and kit for the early detection of sepsis.
KR20230042301A (en)2020-08-042023-03-28애벗트 라보라토리이즈 Improved methods and kits for detecting SARS-COV-2 proteins in samples
WO2022029494A1 (en)2020-08-042022-02-10Abbott Rapid Diagnostics International Unlimited CompanyAssays for detecting sars-cov-2
US20220170948A1 (en)2020-12-012022-06-02Abbott LaboratoriesUse of one or more biomarkers to determine traumatic brain injury (tbi) in a human subject having received a head computerized tomography scan that is negative for a tbi
WO2023102384A1 (en)2021-11-302023-06-08Abbott LaboratoriesUse of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
EP4259155A1 (en)2020-12-112023-10-18Reata Pharmaceuticals Holdings, LLCSynthetic triterpenoids for use in therapy
WO2022147147A1 (en)2020-12-302022-07-07Abbott LaboratoriesMethods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
JP2024519858A (en)2021-05-182024-05-21アボット・ラボラトリーズ Methods for assessing brain injury in pediatric subjects
JP2024521476A (en)2021-06-142024-05-31アボット・ラボラトリーズ Methods for diagnosing or aiding in the diagnosis of brain injury caused by acoustic energy, electromagnetic energy, overpressure waves and/or blast waves
EP4392783A1 (en)2021-08-272024-07-03Abbott LaboratoriesMethods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample
CN118715440A (en)2021-08-312024-09-27雅培实验室 Method and system for diagnosing brain injury
CA3230038A1 (en)2021-08-312023-03-09Hongwei ZhangMethods and systems of diagnosing brain injury
WO2023056268A1 (en)2021-09-302023-04-06Abbott LaboratoriesMethods and systems of diagnosing brain injury
CA3240822A1 (en)2021-12-172023-06-22Tony LeeSystems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
WO2023144206A1 (en)2022-01-272023-08-03Sanofi PasteurModified vero cells and methods of using the same for virus production
AU2023216317A1 (en)2022-02-042024-09-05Abbott LaboratoriesLateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
AU2023260822A1 (en)2022-04-292024-11-14Broadwing Bio LlcComplement factor h related 4-specific antibodies and uses thereof
CN119487063A (en)2022-04-292025-02-18博闻生物有限责任公司 Bispecific antibodies and methods for treating eye diseases
KR20250021399A (en)2022-04-292025-02-12브로드윙 바이오 엘엘씨 Angiopoietin-related protein 7-specific antibodies and uses thereof
EP4587842A1 (en)2022-09-152025-07-23Abbott LaboratoriesBiomarkers and methods for differentiating between mild and supermild traumatic brain injury
KR20250068724A (en)2022-09-152025-05-16아보트 러보러터리즈 HBV diagnostic, prognostic and therapeutic methods and products
WO2024163477A1 (en)2023-01-312024-08-08University Of RochesterImmune checkpoint blockade therapy for treating staphylococcus aureus infections
WO2024211475A1 (en)2023-04-042024-10-10Abbott LaboratoriesUse of biomarkers to determine whether a subject has sustained, may have sustained or is suspected of sustaining a subacute acquired brain injury (abi)
WO2024227154A1 (en)2023-04-282024-10-31Broadwing Bio LlcComplement component 3 (c3)-specific antibodies and uses thereof
WO2024226969A1 (en)2023-04-282024-10-31Abbott Point Of Care Inc.Improved assays, cartridges, and kits for detection of biomarkers, including brain injury biomarkers
US12122842B1 (en)2023-09-272024-10-22R&D Systems, Inc.Human CD30-specific binding proteins and uses thereof
WO2025111147A1 (en)2023-11-212025-05-30Abbott LaboratoriesTwo-dimensional matrix droplet array

Citations (29)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4426451A (en)*1981-01-281984-01-17Eastman Kodak CompanyMulti-zoned reaction vessel having pressure-actuatable control means between zones
US4756884A (en)*1985-08-051988-07-12Biotrack, Inc.Capillary flow device
US4948961A (en)*1985-08-051990-08-14Biotrack, Inc.Capillary flow device
US4963498A (en)*1985-08-051990-10-16BiotrackCapillary flow device
US4983038A (en)*1987-04-081991-01-08Hitachi, Ltd.Sheath flow type flow-cell device
US5004923A (en)*1985-08-051991-04-02Biotrack, Inc.Capillary flow device
US5051237A (en)*1988-06-231991-09-24P B Diagnostic Systems, Inc.Liquid transport system
US5137808A (en)*1987-04-071992-08-11Syntex (U.S.A.) Inc.Immunoassay device
US5140161A (en)*1985-08-051992-08-18BiotrackCapillary flow device
US5144139A (en)*1985-08-051992-09-01Biotrack, Inc.Capillary flow device
US5164598A (en)*1985-08-051992-11-17BiotrackCapillary flow device
US5204525A (en)*1985-08-051993-04-20BiotrackCapillary flow device
US5458852A (en)*1992-05-211995-10-17Biosite Diagnostics, Inc.Diagnostic devices for the controlled movement of reagents without membranes
US5744366A (en)*1992-05-011998-04-28Trustees Of The University Of PennsylvaniaMesoscale devices and methods for analysis of motile cells
US5885527A (en)*1992-05-211999-03-23Biosite Diagnostics, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US5922615A (en)*1990-03-121999-07-13Biosite Diagnostics IncorporatedAssay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
US5939272A (en)*1989-01-101999-08-17Biosite Diagnostics IncorporatedNon-competitive threshold ligand-receptor assays
US6074616A (en)*1998-01-052000-06-13Biosite Diagnostics, Inc.Media carrier for an assay device
US6106779A (en)*1997-10-022000-08-22Biosite Diagnostics, Inc.Lysis chamber for use in an assay device
US6113855A (en)*1996-11-152000-09-05Biosite Diagnostics, Inc.Devices comprising multiple capillarity inducing surfaces
US6143576A (en)*1992-05-212000-11-07Biosite Diagnostics, Inc.Non-porous diagnostic devices for the controlled movement of reagents
US6156270A (en)*1992-05-212000-12-05Biosite Diagnostics, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6194222B1 (en)*1998-01-052001-02-27Biosite Diagnostics, Inc.Methods for monitoring the status of assays and immunoassays
US6302919B1 (en)*1999-07-202001-10-16Brian ChambersReverse-flow centrifugal filtration method
US6391265B1 (en)*1996-08-262002-05-21Biosite Diagnostics, Inc.Devices incorporating filters for filtering fluid samples
US6392894B1 (en)*1998-01-052002-05-21Biosite IncorporatedMedia carrier for an assay device
US20020190356A1 (en)*1998-01-052002-12-19Biosite IncorporatedMedia carrier for an assay device
US20040077103A1 (en)*1992-05-212004-04-22Biosite, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US20050112782A1 (en)*1992-05-212005-05-26Biosite, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE105084C (en)*
AT105084B (en)*1925-01-051926-12-27Walther Dr Traxl Process for the extraction of precious metals from thiosulphate or polythionate solutions with simultaneous regeneration of the solution.
US4539182A (en)*1983-04-081985-09-03Miles Laboratories, Inc.Automated reagent blotter
US5079142A (en)*1987-01-231992-01-07Synbiotics CorporationOrthogonal flow immunoassays and devices
JPS63262565A (en)*1987-04-201988-10-28Hitachi Ltd flow cell
US5202268A (en)*1988-12-301993-04-13Environmental Diagnostics, Inc.Multi-layered test card for the determination of substances in liquids

Patent Citations (38)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4426451A (en)*1981-01-281984-01-17Eastman Kodak CompanyMulti-zoned reaction vessel having pressure-actuatable control means between zones
US5140161A (en)*1985-08-051992-08-18BiotrackCapillary flow device
US5204525A (en)*1985-08-051993-04-20BiotrackCapillary flow device
US4963498A (en)*1985-08-051990-10-16BiotrackCapillary flow device
US4756884A (en)*1985-08-051988-07-12Biotrack, Inc.Capillary flow device
US5004923A (en)*1985-08-051991-04-02Biotrack, Inc.Capillary flow device
US5164598A (en)*1985-08-051992-11-17BiotrackCapillary flow device
US4948961A (en)*1985-08-051990-08-14Biotrack, Inc.Capillary flow device
US5144139A (en)*1985-08-051992-09-01Biotrack, Inc.Capillary flow device
US5137808A (en)*1987-04-071992-08-11Syntex (U.S.A.) Inc.Immunoassay device
US4983038A (en)*1987-04-081991-01-08Hitachi, Ltd.Sheath flow type flow-cell device
US5051237A (en)*1988-06-231991-09-24P B Diagnostic Systems, Inc.Liquid transport system
US5939272A (en)*1989-01-101999-08-17Biosite Diagnostics IncorporatedNon-competitive threshold ligand-receptor assays
US6297060B1 (en)*1990-03-122001-10-02Biosite Diagnostics, Inc.Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
US5922615A (en)*1990-03-121999-07-13Biosite Diagnostics IncorporatedAssay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
US5744366A (en)*1992-05-011998-04-28Trustees Of The University Of PennsylvaniaMesoscale devices and methods for analysis of motile cells
US5458852A (en)*1992-05-211995-10-17Biosite Diagnostics, Inc.Diagnostic devices for the controlled movement of reagents without membranes
US6019944A (en)*1992-05-212000-02-01Biosite Diagnostics, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US20050136552A1 (en)*1992-05-212005-06-23Biosite, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6905882B2 (en)*1992-05-212005-06-14Biosite, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US20050112782A1 (en)*1992-05-212005-05-26Biosite, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6143576A (en)*1992-05-212000-11-07Biosite Diagnostics, Inc.Non-porous diagnostic devices for the controlled movement of reagents
US6156270A (en)*1992-05-212000-12-05Biosite Diagnostics, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6767510B1 (en)*1992-05-212004-07-27Biosite, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6271040B1 (en)*1992-05-212001-08-07Biosite Diagnostics IncorporatedDiagnostic devices method and apparatus for the controlled movement of reagents without membranes
US5885527A (en)*1992-05-211999-03-23Biosite Diagnostics, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US20040077103A1 (en)*1992-05-212004-04-22Biosite, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6391265B1 (en)*1996-08-262002-05-21Biosite Diagnostics, Inc.Devices incorporating filters for filtering fluid samples
US20030035758A1 (en)*1996-08-262003-02-20Biosite IncorporatedDevices for incorporating filters for filtering fluid samples
US6669907B1 (en)*1996-11-152003-12-30Biosite, Inc.Devices comprising multiple capillarity inducing surfaces
US6113855A (en)*1996-11-152000-09-05Biosite Diagnostics, Inc.Devices comprising multiple capillarity inducing surfaces
US6106779A (en)*1997-10-022000-08-22Biosite Diagnostics, Inc.Lysis chamber for use in an assay device
US6392894B1 (en)*1998-01-052002-05-21Biosite IncorporatedMedia carrier for an assay device
US20020190356A1 (en)*1998-01-052002-12-19Biosite IncorporatedMedia carrier for an assay device
US6194222B1 (en)*1998-01-052001-02-27Biosite Diagnostics, Inc.Methods for monitoring the status of assays and immunoassays
US6074616A (en)*1998-01-052000-06-13Biosite Diagnostics, Inc.Media carrier for an assay device
US20070154970A1 (en)*1998-01-052007-07-05Biosite, Inc.Methods for monitoring the status of assays and immunoassays
US6302919B1 (en)*1999-07-202001-10-16Brian ChambersReverse-flow centrifugal filtration method

Cited By (14)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US7824611B2 (en)1992-05-212010-11-02Biosite, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US20050136552A1 (en)*1992-05-212005-06-23Biosite, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US7615191B2 (en)1992-05-212009-11-10Biosite, Inc.Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US20070154970A1 (en)*1998-01-052007-07-05Biosite, Inc.Methods for monitoring the status of assays and immunoassays
US7713703B1 (en)2000-11-132010-05-11Biosite, Inc.Methods for monitoring the status of assays and immunoassays
US7564045B2 (en)2005-06-172009-07-21Amic AbOptical assay system
US20060289787A1 (en)*2005-06-172006-12-28Amic AbOptical assay system
US20100296972A1 (en)*2008-02-012010-11-25Toru MiuraFlow cell
US8241589B2 (en)*2008-02-012012-08-14Nippon Telegraph And Telephone CorporationFlow cell
US9329128B2 (en)2008-11-072016-05-03Roche Diabetes Care, Inc.Test element for detecting an analyte in a sample
WO2020068548A1 (en)*2018-09-252020-04-02Siemens Healthcare Diagnostics Inc.Compositions, kits, and methods for multiplex assays to correct for biotin interference in target analyte measurements
CN112673113A (en)*2018-09-252021-04-16美国西门子医学诊断股份有限公司Compositions, kits and methods for correcting multiplex assays for biotin interference in target analyte measurements
US11287429B2 (en)2018-09-252022-03-29Siemens Healthcare Diagnostics Inc.Compositions, kits, and methods for multiplex assays to correct for biotin interference in target analyte measurements
US12099063B2 (en)2018-09-252024-09-24Siemens Healthcare Diagnostics Inc.Compositions, kits, and methods for multiplex assays to correct for biotin interference in target analyte measurements

Also Published As

Publication numberPublication date
WO1998021563A1 (en)1998-05-22
AU5438598A (en)1998-06-03
US6113855A (en)2000-09-05
EP0938659B1 (en)2003-03-05
US6669907B1 (en)2003-12-30
DE69719536T2 (en)2003-11-06
DE69719536D1 (en)2003-04-10
EP0938659A1 (en)1999-09-01
ATE233896T1 (en)2003-03-15

Similar Documents

PublicationPublication DateTitle
US6669907B1 (en)Devices comprising multiple capillarity inducing surfaces
WO1998021563A9 (en)Devices comprising multiple capillarity inducing surfaces
US5182082A (en)Multiple aliquot device for distributing a liquid solution into a well
US5744366A (en)Mesoscale devices and methods for analysis of motile cells
EP1246698B1 (en)Ultra high throughput sampling and analysis systems and methods
US5503985A (en)Disposable device for diagnostic assays
US5296375A (en)Mesoscale sperm handling devices
US20050161414A1 (en)8GC platform
US8420024B2 (en)Bent microstructures for sampling, transporting or dispensing a fluid media
JP3574932B2 (en) Cuvette matrix
US20050165287A1 (en)Blood bank testing workstations
US8307531B2 (en)Apparatus and method of manufacturing bodily fluid test strip
US20100173423A1 (en)Multiple testing apparatus and method
JPWO2007111347A1 (en) Microplate processing apparatus and microplate processing method
JPWO2007081000A1 (en) Deformable dispensing tip, deformable dispensing device, and modified dispensing method
AU8301598A (en)Collection container assembly
JP2007517200A (en) Disposable reaction container with integrated optical element
US20090260458A1 (en)High throughput dispenser
US20040048361A1 (en)Substrate for microarray
RoseApplication of a novel microarraying system in genomics research and drug discovery
US20220042919A1 (en)Optofluidic diagnostics system
US20060057580A1 (en)Biochip with maximization of the reactor number
KR200230956Y1 (en)Bio chip set for diagnosis
ES2656080T3 (en) Preliminary Diagnostic System
Gray et al.SU-8 structures for integrated high-speed screening

Legal Events

DateCodeTitleDescription
ASAssignment

Owner name:GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, MA

Free format text:SECURITY AGREEMENT;ASSIGNOR:BIOSITE INCORPORATED;REEL/FRAME:019519/0929

Effective date:20070629

Owner name:GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT,MAR

Free format text:SECURITY AGREEMENT;ASSIGNOR:BIOSITE INCORPORATED;REEL/FRAME:019519/0929

Effective date:20070629

ASAssignment

Owner name:GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, MA

Free format text:SECURITY AGREEMENT;ASSIGNOR:BIOSITE INCORPORATED;REEL/FRAME:019523/0276

Effective date:20070629

Owner name:GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT,MAR

Free format text:SECURITY AGREEMENT;ASSIGNOR:BIOSITE INCORPORATED;REEL/FRAME:019523/0276

Effective date:20070629

STCBInformation on status: application discontinuation

Free format text:ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION


[8]ページ先頭

©2009-2025 Movatter.jp